Zum Inhalt

Delayed gastric emptying is associated with increased risk of mortality in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma

  • Open Access
  • 30.10.2022
  • Original Article
Erschienen in:

Abstract

Delayed gastric emptying (DGE) is common in patients undergoing pancreaticoduodenectomy (PD). The effect of DGE on mortality is less clear. We sought to identify predictors of mortality in patients undergoing PD for pancreatic adenocarcinoma hypothesizing DGE to independently increase risk of 30-day mortality. The ACS-NSQIP targeted pancreatectomy database (2014–2017) was queried for patients with pancreatic adenocarcinoma undergoing PD. A multivariable logistic regression analysis was performed. Separate sensitivity analyses were performed adjusting for postoperative pancreatic fistula (POPF) grades A–C. Out of 8011 patients undergoing PD, 1246 had DGE (15.6%). About 8.5% of patients with DGE had no oral intake by postoperative day-14. The DGE group had a longer median operative duration (373 vs. 362 min, p = 0.019), and a longer hospital length of stay (16.5 vs. 8 days, p < 0.001). After adjusting for age, gender, comorbidities, preoperative chemotherapy, preoperative radiation, open versus laparoscopic approach, vascular resection, deep surgical space infection (DSSI), postoperative percutaneous drain placement, and development of a POPF, DGE was associated with an increased risk for 30-day mortality (OR 3.25, 2.16–4.88, p < 0.001). On sub-analysis, grades A and B POPF were not associated with risk of mortality while grade C POPF was associated with increased risk of mortality (OR 5.64, 2.24–14.17, p < 0.001). The rate of DGE in patients undergoing PD in this large database was over 15%. DGE is associated with greater than three times the increased associated risk of mortality, even when controlling for POPF, DSSI, and other known predictors of mortality.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Pancreatic ductal adenocarcinoma (PAC) is the third-leading cause of cancer death in the United States with only 11.5% surviving 5 years after diagnosis [1]. Surgical resection remains the foundation of treatment for non-metastatic PAC [2]. The perioperative mortality of patients undergoing pancreaticoduodenectomy (PD) has decreased to 1–4% [3, 4]. Despite significant improvement in mortality, perioperative morbidity remains substantial. Studies report morbidity rates from 30 to 60%, with common postoperative complications consisting of delayed gastric emptying (DGE) and postoperative pancreatic fistula (POPF) [3, 5].
DGE has been observed to be a complication in a high number of patients (up to 40%) undergoing PD, but whether DGE itself is associated with risk of mortality in PD patients remains unclear [68]. In contrast, POPF occurs in close to 20% of patients undergoing PD and has been shown to be associated with an increased risk of mortality [7, 9, 10]. Many studies have recognized the strong relationship between POPF and the occurrence of DGE [1115], and have proposed that POPF grade C is an independent risk factor for DGE. [16]
This study aimed to assess the risk of mortality in patients with DGE, when controlling for POPF and other significant predictors of mortality, with a hypothesis that DGE is independently associated with an increased risk of 30-day mortality.

Methods

A retrospective analysis of the American College of Surgeons-National Surgery Quality Improvement Program (ACS-NSQIP) targeted pancreatectomy database (2014–2017) was performed. All patients with PAC undergoing PD were identified. Patients with documented DGE were compared to patients without DGE. DGE was defined by NSQIP parameters as no oral intake by postoperative day fourteen or tube to external drainage, or if a nasogastric tube was present or reinserted [17].
The primary outcome was a 30-day mortality. Other outcomes measured were NSQIP-defined postoperative complications: bleeding requiring transfusions > 4 units, organ surgical site infection, deep surgical site infection, surgical site infection, sepsis, septic shock, unplanned intubation, ventilation ≥ 48 h, pneumonia, deep vein thrombosis, urinary tract infection, dehiscence, Clostridium difficile infection, acute renal failure, cardiac arrest with cardiopulmonary resuscitation, myocardial infarction, renal insufficiency, pulmonary embolism, and cerebrovascular accident. Additional outcomes measured included total hospital length of stay (LOS) and intensive care unit (ICU) LOS. The demographic variables collected included age and gender.
Frequency statistics were performed for all available variables. A Student’s t test or Mann–Whitney-U test was used to compare continuous variables, and chi-square was used to compare categorical variables for bivariate analysis. Continuous data were reported as medians with interquartile range or as means with standard deviation. Categorical data were reported as percentages.
The magnitude of the association between predictor variables and mortality was first measured using a univariable logistic regression model. Covariates were chosen by author consensus and review of the literature and included sex, age greater than 65, bleeding disorder, congestive heart failure, chronic obstructive pulmonary disease (COPD), diabetes mellitus, hypertension, smoker, steroid use, weight loss, preoperative chemotherapy, preoperative radiation, vascular resection, percutaneous drain, deep surgical site infection, open operative approach, DGE, and development of POPF [1826]. Covariates with statistical significance (p < 0.20) were included in a hierarchical multivariable logistic regression model and the adjusted risk for mortality was reported with an odds ratio (OR) and 95% confidence intervals (CI). Several studies have reported POPF to be associated with increased risk of DGE and associated with the development of clinical DGE [1116]. Therefore, a separate sensitivity analysis adjusting for POPF grades A-C was performed because POPF could be a significant confounder of our analysis. NSQIP defines POPF as either a clinical diagnosis and NPO-TPN, drain continued longer than 7 days, percutaneous drainage, spontaneous wound drainage, or reoperation; or as persistent drain output of amylase rich fluid in combination with NPO-TPN, a drain continued longer than 7 days, percutaneous drainage, spontaneous wound drainage, or reoperation. NSQIP POPF grades were defined according to the International Study Group on Pancreatic Fistula (ISGPF) guidelines [27]. All p values were two-sided, with a statistical significance level of < 0.05. All analyses were performed with IBM SPSS Statistics for Windows (Version 24, IBM Corp., Armonk, NY).

Results

Demographics and operative characteristics

From 8011 patients undergoing PD for PAC, 1246 developed DGE (15.6%) and 6765 did not (84.4%). Compared to patients without DGE, patients with DGE were more often male (62.0% vs. 52.1%, p < 0.001) and older (median, 69 vs. 67-years-old, p < 0.001). Patients with DGE had higher rates of hypertension (56.7% vs. 52.7%, p = 0.008) and COPD (6.4% vs. 3.9%, p < 0.001). Patients with DGE were less likely to have received chemotherapy (23.5% vs. 29.2, p < 0.001) or radiation therapy within 90 days preoperatively (10.0% vs. 12.4%, p = 0.006), compared to patients without DGE Table 1.
Table 1
Demographics of patients undergoing pancreaticoduodenectomy stratified by delayed gastric emptying
 
DGE
No DGE
 
Characteristic
(n = 1246)
(n = 6765)
P value
 Age, year, median (IQR)
69.0 (61, 75)
67.0 (60, 73)
 < 0.001
 Male, n (%)
773 (62.0%)
3522 (52.1%)
 < 0.001
Comorbidities, n (%)
 Hypertension
707 (56.7%)
3563 (52.7%)
0.008
 Diabetes mellitus
350 (28.1%)
1916 (28.3%)
0.867
 Weight loss
233 (18.7%)
1325 (19.6%)
0.468
 Smoker
193 (15.5%)
1197 (17.7%)
0.059
 COPD
80 (6.4%)
264 (3.9%)
 < 0.001
 Ascites
8 (0.6%)
17 (0.3%)
0.023
 Bleeding disorder
41 (3.3%)
198 (2.9%)
0.488
 Steroid
31 (2.5%)
148 (2.2%)
0.510
 Congestive heart failure
2 (0.2%)
30 (0.4%)
0.146
 End-stage-renal disease
2 (0.2%)
8 (0.1%)
0.698
Functional health status prior to surgery, n (%)
Independent
1231 (98.8%)
6713 (99.2%)
0.308
Partially dependent
1 (0.9%)
1 (0.6%)
0.308
Totally dependent
1 (0.1%)
1 (0.0%)
0.308
Preoperative obstructive jaundice, n (%)
703 (56.4%)
3858 (57.0%)
0.919
Chemotherapy within 90 days, n (%)
293 (23.5%)
1976 (29.2%)
 < 0.001
Radiation therapy within 90 days, n (%)
125 (10.0%)
839 (12.4%)
0.006
DGE Delayed Gastric Emptying, IQR interquartile range, COPD chronic obstructive pulmonary disease
Patients that developed DGE after PD had higher rates of POPF grade A (16.9% vs. 6.6%, p < 0.001), POPF grade B (14.2% vs. 3.5%, p < 0.001), and POPF grade C (4.0% vs. 0.5%, p < 0.001) compared to patients without DGE. Additionally, patients with DGE had higher rates of postoperative percutaneous drain placement compared to patients without DGE (18.9% vs. 8.2%, p < 0.001). There was no difference in the operative approach and vascular resection when comparing patients that developed DGE after PD compared to those without DGE Table 2. The type of anastomosis and its effect on developing DGE could not be studied in more detail given that this was a static variable in the database and the type of anastomosis each patient underwent could not be separated.
Table 2
Operative characteristics of patients undergoing pancreaticoduodenectomy stratified by delayed gastric emptying
 
DGE
No DGE
 
Characteristic
(n = 1246)
(n = 6765)
P value
Operative approach, n (%)
 Open (planned)
1144 (91.8%)
6247 (92.3%)
0.140
 Hybrid
7 (0.4%)
16 (0.2%)
0.140
 Laparoscopic
44 (0.9%)
250 (1.7%)
0.140
 Robotic
51 (3.3%)
249 (3.0%)
0.140
 Pancreatic duct size, n (%)
  < 3 mm
254 (20.4%)
1260 (18.6%)
0.052
 3–6 mm
528 (42.4%)
3050 (45.1%)
0.052
  > 6 mm
168 (13.5%)
1010 (14.9%)
0.052
Pancreatic gland texture, n (%)
 Hard
459 (36.8%)
2842 (42.0%)
 < 0.001
 Intermediate
114 (9.1%)
665 (9.8%)
 < 0.001
 Soft
361 (29.0%)
1572 (23.2%)
 < 0.001
G-J or D-J anastomoses, n (%)
 Antecolic fashion
305 (24.5%)
1771 (26.2%)
 < 0.001
 Retrocolic fashion
136 (10.9%)
743 (11.0%)
 < 0.001
 Not performed
22 (1.8%)
63 (0.9%)
 < 0.001
Vascular resection, n (%)
 Artery
27 (2.2%)
126 (1.9%)
0.248
 Vein
224 (18.0%)
1144 (16.9%)
0.248
 Vein and artery
43 (3.5%)
263 (3.9%)
0.248
 Not performed
934 (75.0%)
5172 (76.5%)
0.248
Drain type, n (%)
 Biliary anastomosis
13 (1.0%)
74 (1.1%)
0.007
 Pancreatic and biliary anastomosis
359 (28.8%)
1774 (26.2%)
0.007
 Pancreatic anastomosis
92 (7.4%)
429 (6.3%)
0.007
 Pancreatic parenchyma
12 (1.0%)
40 (0.6%)
0.007
 Type(s) cannot be determined
59 (4.7%)
234 (3.5%)
0.007
 Drains, n (%)
1120 (89.9%)
5862 (86.7%)
0.007
 Percutaneous drain, n (%)
236 (18.9%)
555 (8.2%)
 < 0.001
 Pancreatic fistula A, n (%)
177 (16.9%)
425 (6.6%)
 < 0.001
Pancreatic fistula B, n (%)
144 (14.2%)
218 (3.5%)
 < 0.001
Pancreatic fistula C, n (%)
36 (4.0%)
29 (0.5%)
 < 0.001
Pancreatic fistula, n (%)
   
CD, Drain continued > 7 days
33 (2.6%)
98 (1.4%)
 < 0.001
CD, NPO-TPN
15 (1.2%)
11 (0.2%)
 < 0.001
CD, Percutaneous drainage performed
57 (4.6%)
102 (1.5%)
 < 0.001
CD, Reoperation performed
22 (1.8%)
23 (0.3%)
 < 0.001
CD, Spontaneous wound drainage
12 (1.0%)
20 (0.3%)
 < 0.001
PD, Drain continued > 7 days
144 (11.6%)
327 (4.8%)
 < 0.001
PD, NPO-TPN
19 (1.5%)
11 (0.2%)
 < 0.001
PD, percutaneous drainage performed
41 (3.3%)
74 (1.1%)
 < 0.001
PD, reoperation performed
14 (1.1%)
6 (0.1%)
 < 0.001
DGE Delayed Gastric Emptying, N/A  Not available, G-J Gastrojejunal, D-J Duodenojejunal, CD Clinical Diagnosis, PD Persistent Drainage, NPO Nothing by mouth, TPN total parenteral nutrition

Predictors of 30-day mortality for PAC patients undergoing PD

On multivariable analysis, DGE was independently associated with increased risk for 30-day mortality (OR 3.25, 2.16–4.88, p < 0.001). Additional associated risk factors for 30-day mortality included: development of POPF (OR 2.31, 1.44–3.70, p < 0.001), vascular resection (OR 1.83, 1.21–2.78, p = 0.005), hypertension (OR 1.62, 1.05–2.49, p = 0.039), and age ≥ 65-years-old (OR 1.61, 1.02–2.53, p < 0.001) Table 3. Preoperative radiation/chemotherapy, sex, diabetes, COPD were not associated with 30-day mortality (all p > 0.05) Table 3. On sub-analysis, grades A and B POPFs were not associated with risk of mortality while grade C POPFs were associated with an increased risk of mortality (OR 5.64, 2.24–14.17, p < 0.001) Table 4.
Table 3
Adjusted* risk of mortality for patients undergoing pancreaticoduodenectomy
Risk factor
OR
CI
P value
Delayed gastric emptying
3.25
2.16–4.88
 < 0.001
Development of pancreatic fistula
2.31
1.44–3.70
 < 0.001
Steroid
1.86
0.73–4.77
0.196
Vascular resection
1.83
1.21–2.78
0.005
COPD
1.64
0.82–3.28
0.163
Hypertension
1.62
1.05–2.49
0.028
Age ≥ 65
1.61
1.02–2.53
0.039
Pre-op radiation
1.49
0.74–3.01
0.268
Organ SSIs
1.49
0.84–2.62
0.171
Gender
1.23
0.82–1.83
0.314
Bleeding disorder
1.28
0.51–3.21
0.605
Smoker
1.13
0.67–1.92
0.643
Diabetes
1.12
0.73–1.70
0.613
Pre-op weight loss
0.97
0.59–1.60
0.899
Post-op percutaneous drain placement
0.90
0.48–1.67
0.727
Pre-op chemotherapy
0.79
0.45–1.36
0.388
Open operative approach
0.68
0.37–1.26
0.217
Congestive heart failure
0.00
0.00–0.00
0.998
COPD chronic obstructive pulmonary disease, Pre-op preoperative, Post-op postoperative, SSIs surgical site infection
Table 4
Adjusted* risk of mortality for pancreaticoduodenectomy adjusting for pancreatic fistula grades
Risk factor
OR
CI
P value
Pancreatic fistula A
1.619
0.87–3.01
0.127
Pancreatic fistula B
1.538
0.67–3.54
0.311
Pancreatic fistula C
5.635
2.24–14.17
 < 0.001
*controlled for: delayed gastric emptying, age > 65, gender, bleeding disorder, congestive heart failure, chronic obstructive pulmonary disease, diabetes mellitus, hypertension, smoker, steroid use, weight loss, preoperative chemotherapy, preoperative radiation, vascular resection, percutaneous drain, deep organ surgical site infection, open operative approach and pancreatic fistula grade (A, B,C)

Other clinical outcomes in PAC patients undergoing PD

Patients that developed DGE had longer operative duration (373 vs. 362 min, p = 0.019), longer LOS (16.5 vs. 8 days, p < 0.001), and greater rate of readmission within 30-days (24.2% vs. 13.3%, p < 0.001) when compared to patients without DGE. Patients with DGE also had higher rates of packed red blood cell transfusions (28.1% vs. 20.0%, p < 0.001), organ surgical site infections (24.0% vs. 9.3%, p < 0.001), sepsis (13.8% vs. 7.3%, p < 0.001), unplanned intubation (10.4% vs. 2.1%, p < 0.001) and mortality (4.0% vs. 0.9%, p < 0.001), as compared to patients without DGE Table 5.
Table 5
Clinical outcomes in patients undergoing pancreaticoduodenectomy stratified by delayed gastric emptying
Outcome
DGE (n = 1246)
No DGE (n = 6765)
P value
Total operation time, minutes, median (IQR)
373 (297.0, 464.5)
362 (282.0, 447.0)
0.019
LOS, days, median (IQR)
16.5 (11, 23)
8.0 (6, 10)
 < 0.001
30-day Readmission, n (%)
301 (24.2%)
897 (13.3%)
 < 0.001
30-day Complications, n (%)
   
Transfusion
350 (28.1%)
1355 (20.0%)
 < 0.001
Organ surgical site infection
299 (24.0%)
630 (9.3%)
 < 0.001
Sepsis
172 (13.8%)
495 (7.3%)
 < 0.001
Surgical site infection
148 (11.9%)
523 (7.7%)
 < 0.001
Unplanned intubation
130 (10.4%)
141 (2.1%)
 < 0.001
Ventilator past 48 h
126 (10.1%)
86 (1.3%)
 < 0.001
Shock
123 (9.9%)
96 (1.4%)
 < 0.001
Pneumonia
111 (8.9%)
156 (2.3%)
 < 0.001
DVT
88 (7.1%)
151 (2.2%)
 < 0.001
UTI
57 (4.6%)
176 (2.6%)
 < 0.001
Dehiscence
41 (3.3%)
44 (0.7%)
 < 0.001
C. difficile
26 (3.2%)
84 (1.8%)
0.009
Renal failure
31 (2.5%)
34 (0.5%)
 < 0.001
Cardiac arrest with CPR
29 (2.3%)
58 (0.9%)
 < 0.001
Myocardial infarction
29 (2.3%)
56 (0.8%)
 < 0.001
Deep surgical site infection
28 (2.2%)
80 (1.2%)
0.003
Renal insufficiency
22 (1.8%)
18 (0.3%)
 < 0.001
Pulmonary embolism
23 (1.8%)
58 (0.9%)
0.001
Cerebrovascular accident
8 (0.6%)
16 (0.2%)
0.016
Mortality, n (%)
50 (4.0%)
62 (0.9%)
 < 0.001
LOS length of total hospital stay, ICU intensive care unit, CPR cardiopulmonary resuscitation, C. difficile = Clostridium difficile, DVT deep vein thrombosis, UTI urinary tract infection, OR operating room

Independent predictors of developing DGE

PF is the highest risk factor for developing DGE (OR 2.71, 2.30–3.19, p < 0.001). Deep organ space infection was the second highest risk factor for developing DGE (OR 1.97, 1.66–2.35, p < 0.001), likely a surrogate measure of PF. Other risk factors included chronic obstructive pulmonary disease (OR 1.63, 1.25–2.14, p < 0.001), age > 65 years old (OR 1.32, 1.15–1.50, p < 0.001) and gender (OR 1.42, 1.25–1.62, p < 0.001).

Discussion

High rates of postoperative morbidity remain a concern for patients undergoing PD. In this retrospective analysis spanning three years, we found that DGE was independently associated with an increased risk of 30-day mortality in patients that had undergone PD for PAC. Other predictors of 30-day mortality included vascular resection, age over 65 years and hypertension. Sex, comorbidities, preoperative chemotherapy, preoperative radiation, and operative approach were not associated with 30-day mortality risk. In a separate sensitivity analysis, we found that grade C POPF was associated with a greater than five-fold increase in associated risk of mortality.
DGE is a leading postoperative complication following PD, with a high reported incidence of up to 25% [3, 68]. Many studies have demonstrated an association of DGE with increased hospital LOS, readmission, delayed adjuvant therapy, and other complications [7, 11, 13, 15]. None of these studies found an independent association of DGE with mortality when controlling for other significant predictors of mortality following PD. Of the retrospective studies identifying postoperative PD mortality risk factors [6, 1922], one study found DGE to be an independent risk factor for long-term pancreatic cancer survival [28]. The results of our current study demonstrate that DGE was independently associated with an increased risk of 30-day mortality following PD for PAC. This is not consistent with the ISGPS guidelines, which state that DGE is not a life-threatening complication [29]. A systematic review of clinical risk factors of DGE by Qu et al., also concluded that DGE was not life-threatening but rather a warning of other severe postoperative complications [11]. The results of the current study suggest that DGE may be addressed as an independent risk factor of mortality, rather than an association with other complications.
Multiple studies have identified risk factors of mortality following PD. Current literature shows that POPF [7, 9, 21] and hypertension [19, 22] are associated with an increased risk of mortality, while surgical approach has no significant difference in mortality [25, 30]. Factors such as age [19, 22] vascular resection [21, 31] comorbidities (COPD, diabetes, smoking) [19, 22] neoadjuvant chemotherapy/radiation [18] and gender [19] have received mixed association with risk of mortality following PD and our study follows this trend. In the current study, we found that that POPF grade C, vascular resection, hypertension, and age greater than 65 years were associated with an increased risk of 30-day mortality. These results are consistent with several studies which demonstrated an association of POPF with mortality [19, 21, 22, 31]. In regards to vascular resection, the results of this study add to the published literature demonstrating an increased risk of 30-day mortality [26, 32, 33]. When evaluating outcomes, the risk associated with hypertension, age greater than 65, and vascular resection should be incorporated into clinician and patient decision making regarding PD for PAC.
POPF remains a common and problematic complication following PD. Several retrospective studies have found Grade C POPF with a mortality rate as high as 30% after PD [7, 9]. However these studies did not control for DGE. Our study adds to existing literature with the finding that grade C POPF was associated with a greater than five-fold increase in risk of 30-day mortality for patients undergoing PD for PDAC, even when controlling for DGE. This reinforces that further work addressing reduction of high-grade pancreatic fistula is needed.
Our study has several limitations including those associated with a retrospective database analysis such as reporting bias, missing data, and misclassification although attempts are made by the ACS to limit these by stringent training requirements of the institutional coders that contribute data to NSQIP. Also, ACS-NSQIP is confined to 30-day outcomes; thus, long-term outcomes are not available. Finally, a significant limitation is that NSQIP does not use the ISGPS definition of DGE, making the definition non uniform with other studies. As such, we were unable to determine if DGE occurred independent of intra-abdominal complications versus concomitant; however, we controlled for these possible confounders during our analyses. Another limitation specific to our study is the inability to separately study the type of anastomosis created for each patient (gastrojejunostomy versus duodenojejunostomy, antecolic versus retrocolic) and its relationship with the development of DGE. Despite these limitations, our study is strengthened by the extensive library of clinical outcomes and variables specific to pancreatic surgery available in this targeted version of the NSQIP database.

Conclusion

In summary, this study utilizing NSQIP found that for patients undergoing PD for PAC, DGE was independently associated with greater than three times the risk for 30-day mortality. In addition, POPF grade C, vascular resection, hypertension, and age greater than 65 years were associated with an increased risk of mortality. Specifically grade C POPF was associated with a greater than five times increased risk for 30-day mortality when controlling for DGE. We propose that DGE should be recognized as an independent risk factor for mortality. Future studies on reduction of occurrence of DGE are warranted.

Declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Research involved animals and humans

This research involved humans. However, since this retrospective study was performed using a national database with deidentified patients, risk to participants is minimal. There is no consent required.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
download
DOWNLOAD
print
DRUCKEN
Titel
Delayed gastric emptying is associated with increased risk of mortality in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma
Verfasst von
Oscar Hernandez Dominguez
Areg Grigorian
Ronald F. Wolf
David K. Imagawa
Jeffry T. Nahmias
Zeljka Jutric
Publikationsdatum
30.10.2022
Verlag
Springer International Publishing
Erschienen in
Updates in Surgery / Ausgabe 3/2023
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-022-01404-4
1.
Zurück zum Zitat National Cancer Institute. SEER Cancer Stat Facts. National Institutes of Health. https://seer.cancer.gov/statfacts/html/pancreas.html. Published 2022. Accessed July 14, 2022.
2.
Zurück zum Zitat Torphy RJ, Fujiwara Y, Schulick RD (2020) Pancreatic cancer treatment: better, but a long way to go. Surg Today 50(10):1117. https://doi.org/10.1007/S00595-020-02028-0CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Narayanan S, Martin AN, Turrentine FE, Bauer TW, Adams RB, Zaydfudim VM (2018) Mortality after pancreaticoduodenectomy: assessing early and late causes of patient death. J Surg Res 231:304–308. https://doi.org/10.1016/J.JSS.2018.05.075CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Panni RZ, Panni UY, Liu J et al (2021) Re-defining a high volume center for pancreaticoduodenectomy. HPB 23(5):733–738. https://doi.org/10.1016/j.hpb.2020.09.009CrossRefPubMed
5.
Zurück zum Zitat Complications SR, Pancreaticoduodenectomy A (2021) Complications after pancreaticoduodenectomy. Surg Clin North Am 101(5):865–874. https://doi.org/10.1016/j.suc.2021.06.011CrossRef
6.
Zurück zum Zitat Zakaria HM, Mohamed A, Alsebaey A, Omar H, ELazab D, Gaballa NK. (2018) Prognostic factors following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Int Surg J. 5(12):3877. https://doi.org/10.18203/2349-2902.isj20185011CrossRef
7.
Zurück zum Zitat Mirrielees JA, Weber SM, Abbott DE, Greenberg CC, Minter RM, Scarborough JE (2020) Pancreatic fistula and delayed gastric emptying are the highest-impact complications after Whipple. J Surg Res 250:80–87. https://doi.org/10.1016/j.jss.2019.12.041CrossRefPubMed
8.
Zurück zum Zitat Ellis RJ, Gupta AR, Hewitt DB et al (2019) Risk factors for post-pancreaticoduodenectomy delayed gastric emptying in the absence of pancreatic fistula or intra-abdominal infection. J Surg Oncol 119(7):925. https://doi.org/10.1002/JSO.25398CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Pedrazzoli S (2017) Pancreatoduodenectomy (PD) and postoperative pancreatic fistula (POPF). Med. https://doi.org/10.1097/MD.0000000000006858CrossRef
10.
Zurück zum Zitat Mungroop TH, Van Rijssen LB, Van Klaveren D et al (2019) Alternative fistula risk score for Pancreatoduodenectomy (a-FRS): design and international external validation. Ann Surg 269(5):937–943. https://doi.org/10.1097/SLA.0000000000002620CrossRefPubMed
11.
Zurück zum Zitat Qu H, Sun GR, Zhou SQ, He QS (2013) Clinical risk factors of delayed gastric emptying in patients after pancreaticoduodenectomy: a systematic review and meta-analysis. Eur J Surg Oncol 39(3):213–223. https://doi.org/10.1016/J.EJSO.2012.12.010CrossRefPubMed
12.
Zurück zum Zitat Parmar AD, Sheffield KM, Vargas GM et al (2013) Factors associated with delayed gastric emptying after pancreaticoduodenectomy. HPB (Oxford) 15(10):763–772. https://doi.org/10.1111/hpb.12129CrossRefPubMed
13.
Zurück zum Zitat Robinson JR, Marincola P, Shelton J, Merchant NB, Idrees K, Parikh AA (2015) Peri-operative risk factors for delayed gastric emptying after a pancreaticoduodenectomy. HPB 17(6):495–501. https://doi.org/10.1111/HPB.12385CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Liu Q-Y, Li L, Xia H-T, Zhang W-Z, Cai S-W, Lu S-C (2016) Risk factors of delayed gastric emptying following pancreaticoduodenectomy. ANZ J Surg 86(1–2):69–73. https://doi.org/10.1111/ans.12850CrossRefPubMed
15.
Zurück zum Zitat Mohammed S II, GVB, McElhany A, Silberfein EJ, Fisher WE. (2017) Delayed gastric emptying following pancreaticoduodenectomy: incidence, risk factors, and healthcare utilization. World J Gastrointest Surg. 9(3):73. https://doi.org/10.4240/WJGS.V9.I3.73CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Addeo P, Delpero JR, Paye F et al (2014) Pancreatic fistula after a pancreaticoduodenectomy for ductal adenocarcinoma and its association with morbidity: a multicentre study of the French surgical association. HPB (Oxford) 16(1):46–55. https://doi.org/10.1111/hpb.12063CrossRefPubMed
17.
Zurück zum Zitat Improvement Q, Data Q. American College of Surgeons National Surgical Quality ImprovementProgram. (October 2018). User Guide for the 2017 ACS NSQIP Participant Use Datafile (PUF).; 2015. https://www.facs.org/-/media/files/quality-programs/nsqip/nsqip_puf_userguide_2017.ashx. Accessed June 7, 2021.
18.
Zurück zum Zitat Franko J, Hsu HW, Thirunavukarasu P, Frankova D, Goldman CD (2017) Chemotherapy and radiation components of neoadjuvant treatment of pancreatic head adenocarcinoma: impact on perioperative mortality and long-term survival. Eur J Surg Oncol 43(2):351–357. https://doi.org/10.1016/J.EJSO.2016.10.021CrossRefPubMed
19.
Zurück zum Zitat Joliat G, Petermann D, Demartines N, Schäfer M (2015) External assessment of the early mortality risk score in patients with adenocarcinoma undergoing pancreaticoduodenectomy. HPB 17(7):605–610. https://doi.org/10.1111/HPB.12422CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Li H-B, Zhou J, Zhao F-Q (2018) A prognostic nomogram for disease-specific survival in patients with pancreatic ductal adenocarcinoma of the head of the pancreas following pancreaticoduodenectomy. Med Sci Monit. https://doi.org/10.12659/MSM.909649CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Pugalenthi A, Protic M, Gonen M et al (2016) Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Surg Oncol 113(2):188–193. https://doi.org/10.1002/jso.24125CrossRefPubMed
22.
Zurück zum Zitat Gleeson EM, Shaikh MF, Shewokis PA et al (2016) WHipple-ABACUS, a simple, validated risk score for 30-day mortality after pancreaticoduodenectomy developed using the ACS-NSQIP database. Surgery 160(5):1279–1287. https://doi.org/10.1016/J.SURG.2016.06.040CrossRefPubMed
23.
Zurück zum Zitat Romano G, Agrusa A, Galia M et al (2015) Whipple’s pancreaticoduodenectomy: surgical technique and perioperative clinical outcomes in a single center. Int J Surg 21:S68–S71. https://doi.org/10.1016/J.IJSU.2015.06.062CrossRefPubMed
24.
Zurück zum Zitat Zaghal A, Tamim H, Sahib R et al (2019) Drain or no drain following pancreaticoduodenectomy: the unsolveD Dilemma. Scand J Surg. https://doi.org/10.1177/1457496919840960CrossRefPubMed
25.
Zurück zum Zitat Nickel F, Haney CM, Kowalewski KF et al (2020) Laparoscopic versus open pancreaticoduodenectomy: a systematic review and meta-analysis of randomized controlled trials. Ann Surg 271(1):54. https://doi.org/10.1097/sla.0000000000003309CrossRefPubMed
26.
Zurück zum Zitat Podda M, Thompson J, Kulli CTG, Tait IS (2017) Vascular resection in pancreaticoduodenectomy for periampullary cancers. A 10 year retrospective cohort study. Int J Surg 39:37–44. https://doi.org/10.1016/J.IJSU.2017.01.042CrossRefPubMed
27.
Zurück zum Zitat Bassi C, Marchegiani G, Dervenis C et al (2017) The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 161(3):584–591. https://doi.org/10.1016/j.surg.2016.11.014CrossRefPubMed
28.
Zurück zum Zitat Futagawa Y, Kanehira M, Furukawa K et al (2017) Impact of delayed gastric emptying after pancreaticoduodenectomy on survival. J Hepatobiliary Pancreat Sci 24(8):466–474. https://doi.org/10.1002/jhbp.482CrossRefPubMed
29.
Zurück zum Zitat Wente MN, Bassi C, Dervenis C et al (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the international study group of pancreatic surgery (ISGPS). Surgery 142(5):761–768. https://doi.org/10.1016/J.SURG.2007.05.005CrossRefPubMed
30.
Zurück zum Zitat Zhang H, Lan X, Peng B, Li B (2019) Is total laparoscopic pancreaticoduodenectomy superior to open procedure? A meta-analysis. World J Gastroenterol 25(37):5711. https://doi.org/10.3748/WJG.V25.I37.5711CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Marsoner K, Langeder R, Csengeri D, Sodeck G, Mischinger HJ, Kornprat P (2016) Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk? Wien Klin Wochenschr 128(15–16):566–572. https://doi.org/10.1007/s00508-016-1024-7CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Kantor O, Talamonti MS, Pitt HA et al (2017) Using the NSQIP pancreatic demonstration project to derive a modified fistula risk score for preoperative risk stratification in patients undergoing pancreaticoduodenectomy. J Am Coll Surg 224(5):816–825. https://doi.org/10.1016/J.JAMCOLLSURG.2017.01.054CrossRefPubMed
33.
Zurück zum Zitat Peng C, Zhou D, Meng L et al (2019) The value of combined vein resection in pancreaticoduodenectomy for pancreatic head carcinoma: a meta-analysis. BMC Surg. https://doi.org/10.1186/S12893-019-0540-6CrossRefPubMedPubMedCentral

Neu im Fachgebiet Chirurgie

Was wächst diesmal Unterkiefer?

Eine 31-jährige, ansonsten gesunde Frau stellte sich in der Kopf- und Halschirurgie mit einer progredient zunehmenden Raumforderung im linken Unterkieferbereich vor. In der Vorgeschichte war ein pleomorphes Adenom reseziert worden. Worum könnte es sich dieses Mal handeln?

Positiver Schnittrand bei Prostatektomie: Ausdehnung ist prognoserelevant

Ob der Nachweis von positiven Schnitträndern nach radikaler Prostatektomie mittelfristig mit einem erhöhten Risiko für biochemische Rezidive und für Metastasen einhergeht, hängt auch von der Ausdehnung des Randbefalls ab.

Liposuktion therapiert das Lipödem am effektivsten

Für die Therapie von Patientinnen – betroffen sind fast ausschließlich Frauen – mit Lipödem existiert eine Reihe von Optionen, mit einem eindeutigen Favoriten in puncto Effektivität. Ein großes Problem ist jedoch die korrekte Diagnose.

Wie Chirurgen durch Missgeschicke zu zweiten Opfern werden

Wenn sich in der Medizin verhängnisvolle Komplikationen oder Fehler ereignen, gibt es neben den betroffenen Patienten oft ein zweites Opfer: die behandelnden Ärztinnen oder Ärzte. Eine dafür besonders anfällige Disziplin ist die Chirurgie.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Bildnachweise
Tonsillektomie Operation/© ShvedKristina - stock.adobe.com (Symbolbild mit Fotomodellen), Arzt stützt sich nachdenklich ab/© Wavebreakmedia / Getty Images / iStock (Symbolbild mit Fotomodell)